Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:1211-1215, doi:10.1016/j.jacc.2008.05.061
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terkelsen, C. J.
Right arrow Articles by Nielsen, T. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Terkelsen, C. J.
Right arrow Articles by Nielsen, T. T.
Related Collections
Right arrowRelated Article

VIEWPOINT AND COMMENTARY

Is There Any Time Left for Primary Percutaneous Coronary Intervention According to the 2007 Updated American College of Cardiology/American Heart Association ST-Segment Elevation Myocardial Infarction Guidelines and the D2B Alliance?

Christian J. Terkelsen, MD, PhD*, Jacob T. Sørensen, MD and Torsten T. Nielsen, MD, DMSc

Department of Cardiology B, Aarhus University Hospital, Aarhus, Denmark

Manuscript received March 26, 2008; revised manuscript received May 13, 2008, accepted May 19, 2008.

* Reprint requests and correspondence: Dr. Christian J. Terkelsen, Department of Cardiology B, Aarhus University Hospital, DK-8200 Aarhus N, Denmark (Email: Christian_Juhl_Terkelsen{at}hotmail.com).

Early reperfusion therapy is essential in the treatment of patients with ST-segment elevation myocardial infarction. Fibrinolytic therapy is a feasible reperfusion strategy to be initiated at any hospital and preferably in the pre-hospital phase. Primary percutaneous coronary intervention (PPCI) is acknowledged as a superior reperfusion strategy when initiated in a timely fashion. It is also the preferred reperfusion therapy in patients who exhibit cardiogenic shock and in patients with contraindications to fibrinolysis. However, in many regions, it is difficult to establish a successful PPCI strategy because it mandates optimal pre-hospital and in-hospital triage to ensure acceptable treatment delays. The 2007 updated American College of Cardiology/American Heart Association ST-Segment Elevation Myocardial Infarction Guidelines stress that "the focus for PPCI is from first medical contact because in regionalization strategies, extra time may be taken to transport patients to a center that performs the procedure" and that "time from Emergency Medical Services arrival to balloon inflation should be <90 minutes." When considering fibrinolysis, however, the guidelines accept a door-to-needle time of 30 min from arrival at the local hospital. Is there evidence to justify that, in the PPCI setting, the clock starts ticking upon the arrival of the Emergency Medical Services but, in the setting of in-hospital fibrinolysis, it does not start until a patient's arrival at the local hospital?

Key Words: myocardial infarction • primary percutaneous coronary intervention • percutaneous coronary intervention-related delay • fibrinolysis • guidelines

Abbreviations and Acronyms
  D2B = door-to-balloon
  EMS = Emergency Medical Services
  PCI-related delay = extra treatment delay when performing primary percutaneous coronary intervention instead of fibrinolysis
  PPCI = primary percutaneous coronary intervention
  STEMI = ST-segment elevation myocardial infarction


Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A32. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
G. A. Lamas, E. Escolar, and D. P. Faxon
Review Article: Examining Treatment of ST-Elevation Myocardial Infarction: The Importance of Early Intervention
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2010; 15(1): 6 - 16.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
C. J. Terkelsen, J. T. Sorensen, T. T. Nielsen, and E. Boersma
Percutaneous Coronary Intervention Related Delay in ST-Segment Elevation Myocardial Infarction Patients.
J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1244 - 1244.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. M. Antman
Reply.
J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1244 - 1245.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Vasaiwala and M. I. Vidovich
Door-to-balloon and door-to-needle time for ST-segment elevation myocardial infarction in the U.S.
J. Am. Coll. Cardiol., March 10, 2009; 53(10): 902 - 902.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. J. Terkelsen, J. T. Sorensen, and T. T. Nielsen
Reply
J. Am. Coll. Cardiol., March 10, 2009; 53(10): 902 - 903.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008.
J. Am. Coll. Cardiol., January 27, 2009; 53(4): 373 - 398.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. M. Antman
Time Is Muscle: Translation Into Practice
J. Am. Coll. Cardiol., October 7, 2008; 52(15): 1216 - 1221.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement